Zobrazeno 1 - 9
of 9
pro vyhledávání: '"B A, Hynd"'
Publikováno v:
Scopus-Elsevier
This study reports on the synthesis of two fluorescent analogues of thymopentin (TP-5; Arg-Lys-Asp-Val-Tyr). A fluorescein isothiocyanate labeled analogue (FITC-TP-5) and a stilbene isothiocyanate labeled analogue (SITS-TP-5) were extensively purifie
Publikováno v:
Journal of Lipid Research, Vol 22, Iss 5, Pp 800-810 (1981)
A specific, accurate, and sensitive double antibody radioimmunoassay for measuring human apolipoprotein (apo) C-III has been developed. Anti-apoC-III(1) developed in rabbits cross-reacted completely with apoC-III subspecies. Analytical isoelectric fo
Externí odkaz:
https://doaj.org/article/f9a0522577f844d8886858fc25297aba
Publikováno v:
Journal of Lipid Research, Vol 21, Iss 4, Pp 491-495 (1980)
When total protein in very low density lipoprotein samples is measured by the method of Lowry et al. (1951. J. Biol. Chem 193:265-275), turbidity remains in the final color reaction. Addition of 0.1 ml of 2.5% (v/v) solution of Triton X-100 removes t
Externí odkaz:
https://doaj.org/article/6de53dd7d1ca421dbc31ad94158997a3
Autor:
S L, Nelson, B A, Hynd
Publikováno v:
Clinical chemistry. 39(9)
Autor:
M R, Taskinen, C J, Glueck, M L, Kashyap, L S, Srivastava, B A, Hynd, G, Perisutti, K, Robinson, P J, Kinnunen, T, Kuusi
Publikováno v:
Atherosclerosis. 37(2)
Post-heparin lipoprotein lipase (PH-LPL)-high density lipoprotein cholesterol (HDL-C) interrrelationships were assessed in 9 subjects with documented familial hyperalphalipoproteinemia (FHA) and in 8 controls to focus on potential biochemical etiolog
Publikováno v:
Diagnostic and clinical immunology. 5(4)
The use of monoclonal antibodies and flow cytometry to characterize lymphocyte subsets has become an essential part of immunological research. In this study, we determined the normal ranges and absolute numbers of cells for several lymphocyte subsets
Publikováno v:
The American journal of medicine. 77(3)
A new case of C-II anapolipoproteinemia (complete apolipoprotein C-II deficiency) as the cause of severe hypertriglyceridemia with chylomicronemia (type I lipoprotein phenotype) is described. The patient was a five-year-old boy living in Connecticut.
Autor:
G. Perisutti, B. A. Hynd, Moti L. Kashyap, Donald W. Brady, L S Srivastava, Charles J. Glueck, Peter S. Gartside
Publikováno v:
Atherosclerosis. 35(1)
Plasma apolipoprotein (apo CII), apo CII in plasma very low density lipoproteins (VLDL), plasma post-heparin lipoprotein lipase (LPL) activity and urinary apo CII excretion were assessed in 9 patients with nephrotic syndrome. Apo CII comprised a sign
Autor:
Moti L. Kashyap, Donald W. Brady, G. Perisutti, B. A. Hynd, Peter S. Gartside, L S Srivastava, Charles J. Glueck
Publikováno v:
Lipids. 13(12)
The purpose of these studies was (a) to examine the relationship between total plasma triglycerides (TG) and the amount of apolipoprotein CII (apo CII) in triglyceride rich lipoproteins (TRL), and (b) to determine whether TRL could be enriched with a